abstract |
The compounds of formula (I) below have pharmacologically valuable properties and are particularly useful as NK1 antagonists and inhibitory antagonists.n n n n n n n n Wherein Ring A and Ring B are each as defined in the specification.n n n The compounds are prepared in a manner known per se. |